Organ Preservation With Tislelizumab and Total Neoadjuvant Therapy in Patients With Low Rectal Cancer: RELIEVE -01 Study | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Organ Preservation With Tislelizumab and Total Neoadjuvant Therapy in Patients With Low Rectal Cancer: RELIEVE -01 Study	Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, colorectal neoplasm, digestive system disorder, digestive system neoplasm, intestinal disorder, neoplasm, rectal cancer, rectal disorder, rectal neoplasm	Not yet recruiting	Phase 2	2024-04-30		NCT06390982

8 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
First Hospital of China Medical University	92
Fudan University	653
Hebei Medical University Fourth Hospital	83
Huadong Hospital	23
Liaoning Cancer Hospital & Institute	53
RenJi Hospital	264
Shanghai Changzheng Hospital	79
Shanghai Zhongshan Hospital	347

0 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
No products are listed yet.